The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Insulin Lantus - dokumenterade fördelar jämfört med NPH-insulin [Documented advantages of insulin Lantus when compared with NPH insulin]

På svenska

Author

  • Anders Frid

Publishing year

2004

Language

English

Pages

16-3014

Publication/Series

Läkartidningen

Volume

101

Issue

39

Document type

Journal article

Publisher

Swedish Medical Association

Topic

  • Endocrinology and Diabetes

Keywords

  • Comparative Study
  • Diabetes Mellitus
  • Hypoglycemic Agents: therapeutic use
  • Insulin: administration & dosage
  • Insulin: analogs & derivatives
  • Insulin: therapeutic use
  • Insulin
  • Hypoglycemic Agents: administration & dosage
  • Type I: drug therapy
  • Human
  • Isophane: therapeutic use
  • Isophane: administration & dosage
  • Practice Guidelines

Status

Published

ISBN/ISSN/Other

  • ISSN: 0023-7205